Gene · 53353
Papers2,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37280069 | PubTator, text mining | PubMed |
| SDH mutations, as potential predictor of chemotherapy prognosis in small cell lung cancer patients. | Discov Oncol | 2023 | 37273084 | PubTator, text mining | PubMed |
| To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations. | J Cancer Res Clin Oncol | 2023 | 37261523 | PubTator, text mining | PubMed |
| An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma. | Respir Res | 2023 | 37259066 | PubTator, text mining | PubMed |
| Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in gastric cancer. | Sci Rep | 2023 | 37258571 | PubTator, text mining | PubMed |
| Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy. | Oxid Med Cell Longev | 2023 | 37251440 | PubTator, text mining | PubMed |
| Targeted Treatment of Soft-Tissue Sarcoma. | J Pers Med | 2023 | 37240900 | PubTator, text mining | PubMed |
| lncRNA TRHDE-AS1 Correlated with Genomic Landscape and Clinical Outcome in Glioma. | Genes (Basel) | 2023 | 37239411 | PubTator, text mining | PubMed |
| Development and validation of a gene expression-based nomogram to predict the prognosis of patients with cholangiocarcinoma. | J Cancer Res Clin Oncol | 2023 | 37222808 | PubTator, text mining | PubMed |
| Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer. | Genome Biol | 2023 | 37221612 | PubTator, text mining | PubMed |
| A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer. | Front Immunol | 2023 | 37215130 | PubTator, text mining | PubMed |
| Impact of mini-driver genes in the prognosis and tumor features of colorectal cancer samples: a novel perspective to support current biomarkers. | PeerJ | 2023 | 37214090 | PubTator, text mining | PubMed |
| Role of Single Nucleotide Polymorphism-Related Genes in Tumour Immune Cell Infiltration and Prognosis of Cutaneous Melanoma. | Biomed Res Int | 2023 | 37205232 | PubTator, text mining | PubMed |
| Preliminary radiogenomic study of hepatitis B virus-related hepatocellular carcinoma: associations between MRI features and mutations. | Per Med | 2023 | 37199498 | PubTator, text mining | PubMed |
| Characteristic of molecular subtype based on lysosome-associated genes reveals clinical prognosis and immune infiltration of gastric cancer. | Front Oncol | 2023 | 37197421 | PubTator, text mining | PubMed |
| T cell-mediated tumor killing patterns in head and neck squamous cell carcinoma identify novel molecular subtypes, with prognosis and therapeutic implications. | PLoS One | 2023 | 37192179 | PubTator, text mining | PubMed |
| Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910. | Cancer Sci | 2023 | 37189003 | PubTator, text mining | PubMed |
| Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability. | Front Oncol | 2023 | 37188189 | PubTator, text mining | PubMed |
| Adipose tissue area is a predictive biomarker for the efficacy of pegylated liposomal doxorubicin in platinum-refractory/resistant ovarian cancer. | Cancer Med | 2023 | 37184128 | PubTator, text mining | PubMed |
| Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer. | Cancer Med | 2023 | 37184108 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53353/papers?page=20